Cargando…
Long-term impact of hymenoptera venom immunotherapy on clinical course, immune parameters, and psychosocial aspects
Background: Venom immunotherapy (VIT) is highly efficient in subjects suffering from IgE-mediated allergy to hymenoptera venom (HV), and VIT results in substantial improvement of quality of life (QoL). However, VIT-induced tolerance may be lost over time after cessation of treatment, putting patient...
Autores principales: | Adelmeyer, Jan, Pickert, Julia, Pfützner, Wolfgang, Möbs, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dustri-Verlag Dr. Karl Feistle
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841418/ https://www.ncbi.nlm.nih.gov/pubmed/33521509 http://dx.doi.org/10.5414/ALX02175E |
Ejemplares similares
-
Nanobody‐based human antibody formats act as IgE surrogate in hymenoptera venom allergy
por: Aagaard, Josephine Baunvig, et al.
Publicado: (2022) -
Hymenoptera venom allergy: work disability and occupational impact of venom immunotherapy
por: Paolocci, Giulia, et al.
Publicado: (2014) -
Specific immunotherapy in Albanian patients with anaphylaxis to hymenoptera venoms
por: Mingomataj, Ervin, et al.
Publicado: (2002) -
Simultaneous Influenza Vaccination and Hymenoptera Venom Immunotherapy Is Safe
por: Czerwińska, Ewa, et al.
Publicado: (2021) -
Hymenoptera Venom Immunotherapy in Dogs: Safety and Clinical Efficacy
por: Rostaher, Ana, et al.
Publicado: (2023)